Willow Biosciences Stock Analysis
| WLLW Stock | CAD 0.07 0.01 6.25% |
Willow Biosciences is overvalued with Real Value of 0.0714 and Hype Value of 0.08. The main objective of Willow Biosciences stock analysis is to determine its intrinsic value, which is an estimate of what Willow Biosciences is worth, separate from its market price. There are two main types of Willow Biosciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Willow Biosciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Willow Biosciences' stock to identify patterns and trends that may indicate its future price movements.
The Willow Biosciences stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Willow Biosciences is usually not traded on Canada Day, Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Willow Stock trading window is adjusted to America/Toronto timezone.
Willow |
Willow Stock Analysis Notes
About 24.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.05. Willow Biosciences last dividend was issued on the 27th of March 2017. The entity had 1:25 split on the 21st of May 2019. Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada. WILLOW BIOSCIENCES is traded on Toronto Stock Exchange in Canada. For more information please call Peter SeuferWasserthal at 403 910 5140 or visit https://www.willowbio.com.Willow Biosciences Investment Alerts
| Willow Biosciences generated a negative expected return over the last 90 days | |
| Willow Biosciences has some characteristics of a very speculative penny stock | |
| Willow Biosciences has high historical volatility and very poor performance | |
| Willow Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.17 M. Net Loss for the year was (13.03 M) with profit before overhead, payroll, taxes, and interest of 821 K. | |
| Willow Biosciences has accumulated about 11.01 M in cash with (10.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 24.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: Willow Biosciences Launches 2M Private Placement - TipRanks |
Willow Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Willow Biosciences's market, we take the total number of its shares issued and multiply it by Willow Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Willow Profitablity
Willow Biosciences' profitability indicators refer to fundamental financial ratios that showcase Willow Biosciences' ability to generate income relative to its revenue or operating costs. If, let's say, Willow Biosciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Willow Biosciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Willow Biosciences' profitability requires more research than a typical breakdown of Willow Biosciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.95) | (2.05) | |
| Return On Capital Employed | (2.71) | (2.58) | |
| Return On Assets | (1.95) | (2.05) | |
| Return On Equity | (3.79) | (3.60) |
Management Efficiency
Willow Biosciences has return on total asset (ROA) of (0.7479) % which means that it has lost $0.7479 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.122) %, meaning that it generated substantial loss on money invested by shareholders. Willow Biosciences' management efficiency ratios could be used to measure how well Willow Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of December 2024, Return On Tangible Assets is likely to drop to -2.05. In addition to that, Return On Capital Employed is likely to grow to -2.58. At this time, Willow Biosciences' Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.03 | 0.03 | |
| Tangible Book Value Per Share | 0.03 | 0.03 | |
| Enterprise Value Over EBITDA | (1.03) | (1.09) | |
| Price Book Value Ratio | 3.62 | 3.80 | |
| Enterprise Value Multiple | (1.03) | (1.09) | |
| Price Fair Value | 3.62 | 3.80 | |
| Enterprise Value | 11.4 M | 14.8 M |
Leadership effectiveness at Willow Biosciences is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (1.41) | Beta 1.136 | Return On Assets (0.75) | Return On Equity (2.12) |
Technical Drivers
As of the 11th of December 2024, Willow Biosciences maintains the Mean Deviation of 3.34, standard deviation of 4.8, and Market Risk Adjusted Performance of 0.2468. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Willow Biosciences, as well as the relationship between them.Willow Biosciences Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Willow Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Willow Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Willow Biosciences Outstanding Bonds
Willow Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Willow Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Willow bonds can be classified according to their maturity, which is the date when Willow Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Willow Biosciences Predictive Daily Indicators
Willow Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Willow Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 0.075 | |||
| Day Typical Price | 0.075 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0.01) | |||
| Relative Strength Index | 42.75 |
Willow Biosciences Forecast Models
Willow Biosciences' time-series forecasting models are one of many Willow Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Willow Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Willow Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Willow Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Willow shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Willow Biosciences. By using and applying Willow Stock analysis, traders can create a robust methodology for identifying Willow entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (11.12) | (11.68) | |
| Operating Profit Margin | (11.25) | (11.81) | |
| Net Loss | (11.12) | (11.67) | |
| Gross Profit Margin | (0.56) | (0.59) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Willow Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Other Information on Investing in Willow Stock
Willow Biosciences financial ratios help investors to determine whether Willow Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.